NEW YORK (GenomeWeb) – Stem cell products and services provider Definigen said today it will validate induced pluripotent stem cells for the European Bank for Induced Pluripotent Stem Cells (EBiSC) consortium.

EBiSC is a 26-partner public-private European initiative coordinated by Pfizer and managed by Roslin Cells that will store and distribute iPS cells to global research communities.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.